Enhanced DNA Damages of Human Prostate Cancer Cells Induced by Radiofrequency Capacitive Hyperthermia Pre- and Post X-rays: 6 MV versus 15 MV
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2017-05-17 / Cell J 2017;19(Suppl 1):79-85The Role of Radiofrequency Hyperthermia in The Radiosensitization of A Human Prostate Cancer Cell Line
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2017-05-17 / Cell J 2017;19(Suppl 1):86-95Treatment outcome analysis of chemotherapy combined with modulated electro-hyperthermia compared with chemotherapy alone for recurrent cervical cancer, following irradiation
/in Cervical Cancer, Hyperthermia, International Publications /von 2017-05-04 / Oncol Lett 2017 Jul;14(1):73-78Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells
/in Acute Leukemia, Hyperthermia, International Publications /von 2017-04-28 / J. Therm. Biol. 2017 Jul;67:9-14Temperature measurements in a capacitive system of deep loco-regional hyperthermia
/in Hyperthermia, International Publications /von 2017-04-27 / Electromagn Biol Med 2017;36(3):248-258A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer
/in Cervical Cancer, Hyperthermia, International Publications /von 2017-04-27 / Radiat Oncol 2017 Apr;12(1):75Treatment outcomes of concurrent hyperthermia and chemoradiotherapy for pancreatic cancer: Insights into the significance of hyperthermia treatment
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2017-04-21 / Oncol Lett 2017 Jun;13(6):4959-4964Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial
/in Hepatocellular Carcinoma, Hyperthermia, International Publications /von 2017-04-13 / Oncotarget 2017 Aug;8(32):52651-52664Reirradiation for locally recurrent breast cancer
/in Breast Cancer, Hyperthermia, International Publications /von 2017-04-07 / Breast 2017 Jun;33:159-165
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de